FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $212,000 | -94.8% | 99,000 | -3.3% | 0.01% | -94.5% |
| Q4 2021 | $4,088,000 | +882.7% | 102,419 | -0.0% | 0.14% | +806.2% |
| Q3 2021 | $416,000 | -17.8% | 102,449 | +0.1% | 0.02% | -23.8% |
| Q2 2021 | $506,000 | -82.5% | 102,388 | -22.4% | 0.02% | -84.4% |
| Q1 2021 | $2,891,000 | -16.2% | 131,884 | -2.0% | 0.14% | -25.0% |
| Q4 2020 | $3,448,000 | +81.8% | 134,587 | -5.6% | 0.18% | +37.4% |
| Q3 2020 | $1,897,000 | -15.0% | 142,589 | -11.7% | 0.13% | -18.6% |
| Q2 2020 | $2,233,000 | +58.6% | 161,464 | +1.4% | 0.16% | +28.8% |
| Q1 2020 | $1,408,000 | -2.9% | 159,191 | -13.5% | 0.12% | +8.7% |
| Q4 2019 | $1,450,000 | +215.2% | 183,946 | +514.2% | 0.12% | +180.5% |
| Q3 2019 | $460,000 | -29.8% | 29,949 | -14.1% | 0.04% | -19.6% |
| Q2 2019 | $655,000 | – | 34,879 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |